Tumor enucleation: A safe treatment alternative for renal cell carcinoma

Expert Review of Anticancer Therapy

Volumn 11, Issue 6, 2011, Pages 893-899

  Laryngakis, Nicholas A ^a   Van Arsdalen, Keith N ^a   Guzzo, Thomas J ^a   Malkowicz, S Bruce ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Perelman Center for Advanced Medicine   (United States)

Author keywords

ablation; enucleation; hereditary renal cell carcinoma; local recurrence; nephron sparing surgery; partial nephrectomy; renal cell carcinoma

Indexed keywords

CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; FAMILIAL CANCER; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PARENCHYMA; LASER SURGERY; MULTIPLE CANCER; NEPHRECTOMY; NEPHRON SPARING SURGERY; NONHUMAN; PARTIAL NEPHRECTOMY; PROGRESSION FREE SURVIVAL; REVIEW; SOLITARY KIDNEY; TUMOR ABLATION; TUMOR VOLUME;

ANIMALS; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; HUMANS; KIDNEY; KIDNEY NEOPLASMS; NEPHRECTOMY; SURVIVAL;

EID: 79959788641     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.68     Document Type: Review

References (58)

1. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J. Urol. 176, 2353-2358 (2006 (Pubitemid 44665976)
2. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96 (2008
3. Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA 281, 1628-1631 (1999 (Pubitemid 29211773)
4. Chow WH, Devessa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 14, 288-301 (2008
5. Huang WC, Levey AS, Serio AM et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 7, 735-740 (2006 (Pubitemid 44283660)
6. Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J. Urol. 182, 435-443 (2009
7. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296-1305 (2004
8. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumor - is there a difference in mortality and cardiovascular outcomes? J. Urol. 181, 55-62 (2009
9. Novick AC, Stewart BH, Straffon RA, Banowsky LH. Partial nephrectomy in the treatment of renal adenocarcinoma. J. Urol. 118, 932-936 (1977 (Pubitemid 8261155)
10. Lerner SE, Hawkins CA, Bluete ML et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J. Urol. 155, 1868-1873 (1996 (Pubitemid 26144074)
11. Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin. Proc. 75, 1236-1242 (2000
12. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J. Urol. 163, 730-736 (2000 (Pubitemid 30091605)
13. Patard J, Shavarts O, Lam JS et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J. Urol. 171, 2181-2185 (2004 (Pubitemid 38625430)
14. Leibovich BC, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. J. Urol. 171, 1066-1070 (2004 (Pubitemid 38327528)
15. Carini M, Minervini A, Lapini A, Masieri L, Serni S. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival. J. Urol. 175, 2022-2026 (2006 (Pubitemid 43668511)
16. Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, Benson MC, McKiernan JM. Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67, 260-264 (2006 (Pubitemid 43189838)
17. Becker F, Siemer S, Hack M, Humke U, Ziegler M, Stockle M. Excellent long-term cancer control with elective nephron-sparing surgery for selected renal cell carcinomas measuring more than 4 cm. Eur. Urol. 49, 1058-1063 (2006
18. Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J. Urol. 163, 442-445 (2000 (Pubitemid 30060489)
19. Herr HW. Partial nephrectomy for unilateral renal carcinoma and a normal contralateral kidney: 10-year follow-up. J. Urol. 161, 33-34 (1999
20. Gill IS, Desai MM, Kaouk JH et al. Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J. Urol. 167, 469-476 (2002
21. Gill IS, Kavoussi LR, Lane BR et al. Comparison of 1800 laparoscopic and open partial nephrectomies for single renal tumors. J. Urol. 178, 41-46 (2007 (Pubitemid 46898481)
22. Gill IS, Colombo JR Jr, Frank I, Moinzadeh A, Kaouk J, Desai M. Laparoscopic partial nephrectomy for hilar tumors. J. Urol. 174, 850-853 (2005 (Pubitemid 41140608)
23. Rogers CG, Metwalli A, Blatt AM et al. Robotic partial nephrectomy for hilar tumors: a multi-institutional analysis. J. Urol. 180, 2353-2356 (2008
24. Porpiglia F, Volpe A, Billia M, Scarpa RM. Laparoscopic versus open partial nephrectomy: analysis of the current literature. Eur. Urol. 53, 732-742 (2008
25. Vermooten V. Indications for conservative surgery in certain renal tumors: a study based on the growth pattern of the cell carcinoma. J. Urol. 64, 200-208 (1950
26. Piper NY, Bishoff JT, Magee C et al. Is a 1 cm margin necessary during nephron-sparing surgery for renal cell carcinoma? Urology 58, 849-852 (2001 (Pubitemid 34017255)
27. Sutherland SE, Resnick MI, Maclennan GT, Goldman HB. Does the size of surgical margin in partial nephrectomy for renal cell caner really matter? J. Urol. 167, 61-64 (2002 (Pubitemid 34024499)
28. Castilla EA, Liou LS, Abrahams NA et al. Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma. Urology 60, 993-997 (2002 (Pubitemid 35447553)
29. Franks ME, Hrebinko RL, Konety BR. Surgical enucleation for the treatment of renal tumors. Urol. Int. 71, 184-189 (2003 (Pubitemid 36928790)
30. Puppo P, Introini C, Calvi P, Naselli A. Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur. Urol. 46, 477-481 (2004 (Pubitemid 39200856)
31. Berdjis N, Hakenberg OW, Zastrow S, Oehlschlager S, Novotny V, Wirth MP. Impact of resection margin status after nephron-sparing surgery for renal cell carcinoma. BJU Int. 97, 1208-1210 (2006 (Pubitemid 43907323)
32. Kutikov A, Van Arsdalen KN, Gershman B et al. Enucleation of renal cell carcinoma with ablation of the tumour base. BJU Int. 102, 688-691 (2008
33. Urena R, Mendez F, Woods M, Thomas R, Davis R. Laparoscopic partial nephrectomy of solid renal masses without hilar clamping using a monopolar radio frequency device. J. Urol. 3, 1054-1056 (2004 (Pubitemid 38327525)
34. Tan YH, Young MD, L'Esperance JO, Preminger GM, Albala DM. Hand-assisted laparoscopic partial nephrectomy without hilar vascular clamping using a saline-cooled, high-density monopolar radiofrequency device. J. Endourol. 9, 883-887 (2004 (Pubitemid 39627571)
35. Herrell SD, Levin BM. Laparoscopic partial nephrectomy: use of the TissueLink hemostatic dissection device. J. Endourol. 4, 449-450 (2005
36. Marshall FF, Taxy JB, Fishman EK, Chang R. The feasibility of surgical enucleation for renal cell carcinoma. J. Urol. 135, 231-234 (1976
37. Blackley SK, Ladaga L, Woolfitt RA, Schellhammer PF. Ex situ study of the effectiveness of enucleation in patients with renal cell carcinoma. J. Urol. 140, 6-10 (1988
38. Li QL, Guan HW, Zhang QP, Zhang LZ, Wang FP, Liu YJ. Optimal margin in nephron-sparing surgery for renal cell carcinoma 4 cm or less. Eur. Urol. 44, 448-451 (2003
39. Minervini A, Cristofano C, Lapini A et al. Histopathologic analysis of peritumoral pseudocapsule and surgical margin status after tumor enucleation for renal cell carcinoma. Eur. Urol. 55, 1410-1418 (2009
40. Ficarra V, Galfano A, Cavalleri S. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations? Eur. Urol. 55, 1315-1320 (2009
41. Novick AC, Zincke H, Neves RJ, Topley HM. Surgical enucleation for renal cell carcinoma. J. Urol. 135, 235-238 (1986 (Pubitemid 16131346)
42. Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow-up. J. Urol. 144, 852-857 (1990 (Pubitemid 20324794)
43. Carini M, Minervini A, Masieri L, Lapini A, Serni S. Simple enucleation for the treatment of PT1a renal cell carcinoma: our 20-year experience. Eur. Urol. 50, 1263-1271 (2006 (Pubitemid 44692920)
44. Pertia A, Managadze L. Long-term results of simple enucleation for the treatment of small renal cell carcinoma. Int. Braz. J. Urol. 6, 640-647 (2006
45. Minervini A, Tuccio A, Lapini A et al. Review of the current status of tumor enucleation for renal cell carcinoma. Arch. Ital. Urol. Androl. 2, 65-71 (2009
46. Yossepowitch O, Thompson RH, Leibovich BC et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J. Urol. 6, 2158-2163 (2008
47. McHale T, Malkowicz SB, Tomaszewski JE, Genega EM. Potential pitfalls in the frozen section evaluation of parenchymal margins in nephron-sparing surgery. Am. J. Clin. Pathol. 6, 902-910 (2002
48. Kubinski DJ, Clark PE, Assimos DG, Hall MC. Utility of frozen section analysis of resection margins during partial nephrectomy. Urology 1, 31-34 (2004 (Pubitemid 38887572)
49. Duvdevani M, Laufer M, Kastin A et al. Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J. Urol. 2, 385-387 (2005
50. Benderev TV, Schaeffer AJ. Efficacy and safety of the Nd:YAG laser in canine partial nephrectomy. J. Urol. 133, 1108-1111 (1985 (Pubitemid 15086812)
51. Melzer RB, Wood TW, Landau ST, Smith JA Jr. Combination of CUSA and neodymium:YAG laser for canine partial nephrectomy. J. Urol. 134, 620-622 (1985 (Pubitemid 16236421)
52. Hernandez AD, Smith JA Jr, Jeppson KG, Terreros DA. A controlled study of the argon beam coagulator for partial nephrectomy. J. Urol. 143, 1062-1065 (1990 (Pubitemid 20156136)
53. Quinlan DM, Naslund MJ, Brendler CB. Application of argon beam coagulation in urological surgery. J. Urol. 147, 410-412 (1992
54. Lapini L, Serni S, Minervini A, Masieri L, Carini M. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients. J. Urol. 174, 57-60 (2005 (Pubitemid 40825670)
55. Minervini A, Serni S, Tuccio A et al. Local recurrence after tumor enucleation for renal cell carcinoma with no ablation of the tumor bed: results of a prospective single-centre study. BJU Int. 107(9), 1394-1399 (2011
56. Duffey BG, Choyke PL, Glenn G et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J. Urol. 172, 63-65 (2004 (Pubitemid 41615039)
57. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J. Urol. 165, 777-781 (2001 (Pubitemid 32156275)
58. Minervini A, Serni S, Giubilei G et al. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy. Eur. J. Surg. Oncol. 5, 521-526 (2009).